These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19075647)

  • 1. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
    De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL
    Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong suppression of high-sensitivity C-reactive protein level and its mediated pro-atherosclerotic effects with simvastatin: in vivo and in vitro studies.
    Yip HK; Sun CK; Chang LT; Wu CJ; Chua S; Fu M
    Int J Cardiol; 2007 Oct; 121(3):253-60. PubMed ID: 17196684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Behrens GM
    N Engl J Med; 2005 Apr; 352(16):1721-2; author reply 1721-2. PubMed ID: 15843678
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic syndrome and hyperlipidemia in HIV-positive patients].
    Behrens GM
    Herz; 2005 Sep; 30(6):458-66. PubMed ID: 16170675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.
    Giralt M; Díaz-Delfín J; Gallego-Escuredo JM; Villarroya J; Domingo P; Villarroya F
    Curr Pharm Des; 2010 Oct; 16(30):3371-8. PubMed ID: 20687888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary heart disease in HIV-infected patients.
    Glesby MJ
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):68-73. PubMed ID: 16091251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes.
    Hanriot D; Bello G; Ropars A; Seguin-Devaux C; Poitevin G; Grosjean S; Latger-Cannard V; Devaux Y; Zannad F; Regnault V; Lacolley P; Mertes PM; Hess K; Longrois D
    Thromb Haemost; 2008 Mar; 99(3):558-69. PubMed ID: 18327405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?
    Behrens GM; Stoll M; Schmidt RE
    Drug Saf; 2000 Jul; 23(1):57-76. PubMed ID: 10915032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease, Statins, and HIV.
    Eckard AR; Meissner EG; Singh I; McComsey GA
    J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S83-92. PubMed ID: 27625435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
    Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
    Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance.
    Best C; Struthers H; Laciny E; Royal M; Reeds DN; Yarasheski KE
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2621-9. PubMed ID: 25938633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.
    Carrillo-Jimenez R; Lamas GA; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):207-10. PubMed ID: 12490965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
    Albert MA; Staggers J; Chew P; Ridker PM;
    Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.